Project description
Novel diagnostic platform for COVID-19 rapid test
The EU-funded DECISION project is developing a new class of COVID-19 diagnostic platforms and tests in a joint effort by teams from Italy, Spain and Germany. The diagnostic platform will enable the rapid detection of COVID-19 infections on-site in any possible setting, including drive-through testing centres, airports or medical offices. The low-cost, miniature, disposable diagnostic platform is powered by a next-generation nucleic acid amplification technology called pulse controlled amplification (PCA®), providing sample-to-answer workflows in less than 15 minutes. The objective is to deliver the molecular diagnostic platform and coronavirus test within five months after the start of the project.
Fields of science
Keywords
Programme(s)
Topic(s)
Funding Scheme
RIA - Research and Innovation action
Coordinator
1210 Wien
Austria
See on map
Participants (4)
Participation ended
20500 Arrasate Mondragon
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
00149 Roma
See on map
53123 Bonn
See on map
82152 Martinsried
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.